- Home
- VATE vs INKT Comparison
VATE vs INKT Comparison
Compare VATE & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- INKT
- Stock Information
- Founded
- VATE 1994
- INKT 2017
- Country
- VATE United States
- INKT United States
- Employees
- VATE N/A
- INKT N/A
- Industry
- VATE Metal Fabrications
- INKT Medicinal Chemicals and Botanical Products
- Sector
- VATE Industrials
- INKT Health Care
- Exchange
- VATE Nasdaq
- INKT Nasdaq
- Market Cap
- VATE 62.0M
- INKT 69.2M
- IPO Year
- VATE 1996
- INKT 2021
- Fundamental
- Price
- VATE $4.32
- INKT $14.78
- Analyst Decision
- VATE
- INKT Buy
- Analyst Count
- VATE 0
- INKT 3
- Target Price
- VATE N/A
- INKT $37.50
- AVG Volume (30 Days)
- VATE 43.4K
- INKT 40.2K
- Earning Date
- VATE 11-05-2025
- INKT 11-13-2025
- Dividend Yield
- VATE N/A
- INKT N/A
- EPS Growth
- VATE N/A
- INKT N/A
- EPS
- VATE N/A
- INKT N/A
- Revenue
- VATE $995,000,000.00
- INKT N/A
- Revenue This Year
- VATE N/A
- INKT N/A
- Revenue Next Year
- VATE N/A
- INKT N/A
- P/E Ratio
- VATE N/A
- INKT N/A
- Revenue Growth
- VATE N/A
- INKT N/A
- 52 Week Low
- VATE $3.35
- INKT $4.56
- 52 Week High
- VATE $13.79
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- VATE 39.51
- INKT 50.55
- Support Level
- VATE $4.53
- INKT $13.53
- Resistance Level
- VATE $4.80
- INKT $16.00
- Average True Range (ATR)
- VATE 0.33
- INKT 1.12
- MACD
- VATE -0.04
- INKT 0.07
- Stochastic Oscillator
- VATE 8.60
- INKT 38.27
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.